Sentence: Similarly , a significant benefit in progression-free survival for carboplatin plus gemcitabine versus carboplatin monotherapy was seen in the Gynecologic Cancer InterGroup trial .
Drug combination annotation:
[{'class': 'POS', 'spans': ['carboplatin', 'gemcitabine'], 'is_context_needed': False}]